Printer Friendly

India : Sale of Spurious Drugs.

Some cases of sale of spurious, sub-standard and expired drugs have been detected by the State Drugs Control Authorities. A statement giving the details of number of drugs samples tested, number of drugs samples declared not of standard quality, number of drug samples declared spurious/ adulterated, number of prosecutions launched for manufacturing, sale and distribution of spurious/ adulterated drugs, number of cases decided, number of persons arrested during 2011-12 and 2012-13 and detection of racket of sale of expired drugs as per the feedback available from the States is annexed.

The Government has also taken the following steps to prevent the sale of spurious/ adulterated drugs:

1. The Drugs and Cosmetics Act, 1940 was amended by the Drugs & Cosmetics (Amendment) Act, 2008 to provide for more stringent penalties for manufacture and trade of spurious and adulterated drugs. Certain offences have also been made cognizable and non-bailable.

2. The Drugs & Cosmetics (Amendment) Act, 2008 has also enabled setting up of special designated courts for speedy disposal of cases to deal with the cases of offences under the Drugs and Cosmetics Act. 17 States/UTs have already set up these special Courts.

3. Guidelines for taking action on samples of drugs declared spurious or not of standard quality in the light of enhanced penalties under the Drugs & Cosmetics (Amendment) Act, 2008 have been forwarded to the State Drugs Controllers for implementation.

4. A Whistle Blower Scheme has been initiated by the Government to encourage vigilant public participation in the detection of movement of spurious drugs in the country. Under this scheme, the informers would be suitably rewarded for providing concrete information in respect of movement of spurious drugs to the regulatory authorities.

5. On the basis of an Order of the Hon ble High Court of Allahabad in the Criminal (Misc) Writ Petition No. 16212/2008 Brahmaji vs State of UP and Others, the Government had constituted a Task Force to examine the feasibility of networking and tracking the drugs distribution system in the country from the manufacturer to the retailer to secure the entire supply chain and detect spurious drugs available in the market. Different options through the use of information technology were considered by the Task Force, including providing bar code on the label of the drugs, for identifying and tracking their movement from the manufacturer to the consumer.

2013 Al Bawaba (

Provided by an company
COPYRIGHT 2013 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Geographic Code:9INDI
Date:Aug 29, 2013
Previous Article:India : Dental Clinics in CGHS Dispensaries.
Next Article:India : Essar Projects wins Rs. 700 crore EPCC order from BPCL.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters